The goal of this application is to determine the mechanisms leading to the overexpression of the urokinase receptor (u-PAR) in invasive colon cancer.
In Specific Aim 1, the applicant proposes to identify the role of an upstream AP-1 motif in the regulation of u-PAR expression and also identify transcription factors bound by this sequence.
Aim 2 will ascertain the role of these promoter regions in regulating u-PAR expression by determining if deletion of either region impairs u-PAR promoter activity, by identifying the nucleotides contacted by nuclear proteins, and by determining the effect of mutation of the contacted nucleotides on u-PAR promoter activity.
Aim 3 will determine the role of extracellular signal-regulated kinases 1 (ERK1) and 2 or a constitutively activated MEK1 which lies upstream of the ERKs, to modulate u-PAR expression and in vitro invasion.
Aim 4 will investigate the ability of a synthetic inhibitor of MEK1 activation to downregulate u-PAR expression and in vitro invasion, and Aim 5 will determine the role of the c-Jun aminoterminal kinase 1 (JNK1) in regulating u-PAR expression. It is hoped that these studies will benefit colon cancer patients by decreasing u-PAR expression in colon cancer and thereby reduce the metastatic spread of the disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA058311-04
Application #
2393435
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1994-07-01
Project End
2002-04-30
Budget Start
1997-07-15
Budget End
1998-04-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Biology
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Chauhan, Santosh; Goodwin, Jinesh G; Chauhan, Swati et al. (2013) ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell 50:16-28
Chauhan, Santosh; Boyd, Douglas D (2012) Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway. Nucleic Acids Res 40:600-13
Avila, Hector; Wang, Heng; Chauhan, Santosh et al. (2011) Accelerated urokinase-receptor protein turnover triggered by interference with the addition of the glycolipid anchor. Biochem J 434:233-42
Ishiguro, T; Avila, H; Lin, S-Y et al. (2010) Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases. Br J Cancer 102:774-82
Nair, Rajesh R; Avila, Hector; Ma, Xujun et al. (2008) A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. Mol Pharmacol 73:919-29
Wang, H; Yan, C; Asangani, I et al. (2007) Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression. Oncogene 26:2058-70
Yan, Chunhong; Boyd, Douglas D (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211:19-26
Nair, Rajesh R; Solway, Julian; Boyd, Douglas D (2006) Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 281:26424-36
Yang, Lin; Avila, Hector; Wang, Heng et al. (2006) Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Cancer Res 66:7957-67
Yan, Chunhong; Boyd, Douglas D (2006) Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol 26:6357-71

Showing the most recent 10 out of 42 publications